​

Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Voyager Therapeutics Ownership Summary

Voyager Therapeutics is owned by 60.74% institutional investors, 16.98% insiders, and 22.28% retail investors. Blackrock is the largest institutional shareholder, holding 9.30% of VYGR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics60.74%16.98%22.28%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.31M9.30%$42.02M
Armistice capital5.20M9.10%$41.13M
Ecor1 capital3.92M6.86%$30.99M
Vanguard group3.04M5.32%$24.04M
Farallon capital management2.29M4.01%$18.13M
State street1.79M3.13%$14.15M
Great point partners1.60M2.80%$12.67M
Geode capital management1.07M1.88%$8.49M
American century companies1.02M1.78%$8.06M
Price t rowe associates inc /md/989.55K1.73%$7.83M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Great point partners1.60M2.43%$12.67M
Ecor1 capital3.92M0.95%$30.99M
Armistice capital5.20M0.52%$41.13M
Vestal point capital, lp600.00K0.35%$4.75M
Globeflex capital l p291.29K0.24%$2.30M
Patriot financial group insurance agency127.89K0.15%$1.01M
Hunter perkins capital management62.02K0.10%$491.00K
Farallon capital management2.29M0.09%$18.13M
Virtus investment advisers12.65K0.08%$100.05K
Clarivest asset management102.82K0.08%$813.32K

Top Buyers

HolderShares% AssetsChange
Great point partners1.60M2.43%1.60M
Blackrock5.31M0.00%915.17K
Armistice capital5.20M0.52%528.00K
Bank of america corp /de/648.76K0.00%294.32K
American century companies1.02M0.00%249.66K

Top Sellers

HolderShares% AssetsChange
Acadian asset management106.83K0.00%-353.02K
Woodline partners lp---300.00K
Dimensional fund advisors lp813.68K0.00%-291.88K
Aqr capital management502.38K0.01%-291.26K
Vanguard group3.04M0.00%-193.13K

New Positions

HolderShares% AssetsChangeValue
Great point partners1.60M2.43%1.60M$12.67M
Omers administration162.40K0.01%162.40K$1.28M
Patriot financial group insurance agency127.89K0.15%127.89K$1.01M
Prudential financial115.30K0.00%115.30K$912.02K
Pdt partners75.70K0.06%75.70K$598.83K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Russell investments group-43.00
Pacer advisors-508.00
Macroview investment management-858.00
Quantbot technologies lp-1.50K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241321.54%35,137,594-5.22%601.47%58-12.12%37-7.50%
Jun 30, 2024129-4.44%37,074,4377.46%641.01%66-26.67%3939.29%
Mar 31, 202413522.73%34,500,82333.24%802.30%9076.47%28-12.50%
Dec 31, 2023110-3.51%25,893,556-1.14%591.63%51-8.93%32-3.03%
Sep 30, 20231144.59%26,192,9431.46%601.49%56-27.27%3365.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.71M3.14%-
iShares Russell 2000 ETF1.21M2.21%-2.72K
Vanguard Institutional Extnd Mkt Idx Tr643.25K1.18%-2.95K
T. Rowe Price Health Sciences622.40K1.14%-12.41K
Fidelity Small Cap Index469.64K0.86%-10.34K
Vanguard Explorer Inv457.06K0.84%-
BlackRock Health Sciences Opps Inv A445.88K0.82%-
iShares Russell 2000 Value ETF444.10K0.81%-
BlackRock Health Sciences Term Trust363.32K0.67%13.62K
iShares Biotechnology ETF320.40K0.59%-1.91K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 02, 2024Fahey Sandell Jacquelyn Chief Legal OfficerSell$34.91K
Apr 02, 2024Swartz Robin Chief Operating OfficerSell$13.41K
Apr 02, 2024Sandrock Alfred President and CEOSell$119.45K
Feb 21, 2024Swartz Robin Chief Operating OfficerSell$29.55K
Feb 21, 2024Sandrock Alfred President and CEOSell$97.23K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3--
2024 Q2-2
2024 Q1-7
2023 Q4-1

VYGR Ownership FAQ

Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 60.74%, followed by 16.98% insiders and 22.28% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 47.04%, which Voyager Therapeutics exceeds.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock (5.31M shares, 9.30%), Armistice capital (5.2M shares, 9.10%), and Ecor1 capital (3.92M shares, 6.86%). Together, they hold 25.26% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.43% of its assets in 1.6M Voyager Therapeutics shares, valued at 12.67M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Voyager Therapeutics shares, with 3.14% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools